MARKET

CNMD

CNMD

CONMED
NYSE

Real-time Quotes | Nasdaq Last Sale

73.33
+0.40
+0.55%
After Hours: 73.33 0 0.00% 16:07 05/22 EDT
OPEN
73.38
PREV CLOSE
72.93
HIGH
73.95
LOW
72.57
VOLUME
310.70K
TURNOVER
--
52 WEEK HIGH
116.81
52 WEEK LOW
37.66
MARKET CAP
2.09B
P/E (TTM)
65.08
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CNMD stock price target is 91.00 with a high estimate of 110.00 and a low estimate of 82.00.

EPS

CNMD News

More
CONMED declares $0.20 dividend
CONMED (NYSE:CNMD) declares $0.20/share quarterly dividend, in line with previous. Forward yield 1.1% Payable July 6; for shareholders of record June 15; e
seekingalpha · 3d ago
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 6, 2020 to all shareholders of record as of June 15, 2020.
Business Wire · 4d ago
Edited Transcript of CNMD earnings conference call or presentation 29-Apr-20 8:30pm GMT
Q1 2020 Conmed Corp Earnings Call
Thomson Reuters StreetEvents · 05/15 16:50
CONMED Corporation to Present at the BofA Securities Virtual Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the BofA Securities Virtual Healthcare Conference at 9:40 a.m
Business Wire · 05/04 20:05
CONMED (CNMD) Q1 Earnings and Revenues Surpass Estimates
Zacks · 05/04 15:56
Stifel Maintains Buy on Conmed, Raises Price Target to $82
Stifel maintains Conmed (NYSE:CNMD) with a Buy and raises the price target from $65 to $82.
Benzinga · 04/30 12:51
Conmed Q1 sales down 2%, adjusted earnings down 9%
CONMED (NYSE:CNMD) Q1 results: Sales: $214.0M (-2.0%). Orthopedic Surgery: $99.3 (-12.4%); General Surgery: $114.7M (+9.2%). Net income: $5.9M (+490.0%); n
seekingalpha · 04/30 02:23
CONMED Corporation (CNMD) CEO Curt Hartman on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 04/29 23:47

Industry

Medical Equipment, Supplies & Distribution
+0.90%
Healthcare Equipment & Supplies
+1.09%

Hot Stocks

Symbol
Price
%Change

About CNMD

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical smoke evacuation products. As of December 31, 2018, the Company's products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company's orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.
More

Webull offers kinds of CONMED Corporation stock information, including NYSE:CNMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNMD stock news, and many more online research tools to help you make informed decisions.